gastrointestinal pharm Flashcards
GERD
1) chronic condition of acid reflux
2) inappropriate relaxation of lower esophageal sphincter
3) indigestion and heartburn
- chest pain
- hoarseness
- asthma
- esophageal and dental erosion
barretts esophagus
1) metaplasia
2) early stage - GERD treatment
3) any dysplasia - resection, cryotherapy, surgery
peptic ucler disease
1) erosion of lining from acid/pepsin
2) involvement of G- bacteria h. pylori in most cases
- cytokine production
3) often NSAID usage implicated in etiology of disease
- can interrupt gastric mucosa integrity
common gastric disease mechnisms
1) arachidonic acid => leukotrienes
2) COX 1 and 2 are targeted by NSAIDs
- COX1 mediates gastric integrity, which you don’t want inhibited (by NSAID or h pylori)
- COX 2 inhibitors are better
acid seretion
1) gastrin - G cell
- gastric distension
2) histamine - enterochromaffin like cell
- gastrin induces histamine
3) acetylcholine - vagal innervation
drugs modifying acid levels
1) PPI
- omepraxole, lansoprazole
- slow acting - longer term
2) histamine receptor antagonists
- cimetidine, famotidine
- faster acting - medium term
3) anticholinergics
- propantheline
- not regularly used
4) antacids
- magnesium oxide, sodium bicarbonate
- immediate effect - short term
zantac
1) do not take Zantac - FDA requests removal of all ranitidine
2) breakdown products on storage are toxic and carcinogenic
adverse reactions
1) PPIs are generally well tolerated
- slight increase in gastrin over time
- some disruption of Ca2+ and Mg2+ metabolism
- potential interaction with CYP2C19 and CYP3A4 mediated drugs including diazepam, clopidogrel, st johns wort
2) non specific adverse reactions from cimetidine
- other H2 antagonists have no sig CYP interactions
- but cytochrome metabolism alters systemic level of many drugs
- anti-androgenic
3) Mg salts
- mess with digestions, diarrhea,
4) AL salts
- constipations
other drugs for GERD and PUD
1) prostaglandin E1 - misoprostol
- increase mucosal blood flow and mucus secretion, reduce histamine and acid secretion
- treats NSAID lesions
2) antibiotics
- clarithromycin, amoxycillin, metronidazole
- usually in combination with two plus PPI or H2 antagonist, treats h. pylori
3) physical protectants
- sodium alginate, sucralfate
- gel covering either gastric fluid or mucosal walls
gastroparesis
1) associated with diabetes
2) enhanced by GLP-1 receptor agonist (ozempic)
3) delayed gastric empty
4) aim of therapy is to
- promote motility
- decrease gastric emptying time
5) drugs for treatment of GERD and anti emetic drugs useful
dental considerations
1) avoid administration of gastric irritants
- NSAIDS, erythromycin, corticosteroids
2) antacids may reduce absorption of many drugs
3) cimetidine competes with other drugs metabolized by CYP450 including lidocaine and diazepam
4) positional reflex alleviated by chair at 45%
anti-emetic drugs
1) broad variety of drugs with targets from the brain to the GIT crossover with prokinetic drugs
2) commonly used during anti cancer therapy
- because potential for nausea and emesis
- dimenhydrinate, metoclopramide, etc. etc.
bethanecol
1) muscarinic receptor agonists
neostigmine
Ach inhib
meocloparamine
dopamine receptor antagonist